Diagnostic soluble fragment of cytokeratin-19 (CYFRA21-1) antibodies (anti-soluble fragment of cytokeratin-19, anti-CYFRA21-1) for Tumor/Cancer CYFRA21-1 detection in ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

CYRFA 21-1 (cytokeratin 19 fragment) has been demonstrated as clinically useful in the prognostication and monitoring of non-small cell lung cancer (NSCLC). Elevated pretreatment levels may be associated with unfavorable prognosis, and decreasing levels during therapy predict an objective response to treatment. CYFRA 21�C1 is a cytoplasmic protein fragment of cytokeratin 19 (CK-19) which is found in various epithelial malignancies, such as lung cancer[, gastrointestinal cancer and cervical cancer. This soluble debris can be released into the blood after tumor cell death, thus exhibiting a close relationship with tumor cell necrosis. Its level could be a proper indicator of necrosis degree. It has been reported that CYFRA 21�C1 is a potential tumor marker for the diagnosis and prognosis of non-small cell lung cancer (NSCLC) and squamous carcinoma of the head and neck. Other studies have confirmed that the serum CYFRA 21�C1 level before treatment is related to poor prognosis in patients with non-metastatic head and neck cancer(HNC).

Genemedi produces core diagnostic ingredients for test of Tumor/Cancer and related syndrome. GeneMedi offers paired diagnostics grade soluble fragment of cytokeratin-19 (CYFRA21-1) ) antibodies (monoclonal antibody, mab) and soluble fragment of cytokeratin-19 (CYFRA21-1) ) antigens for Tumor/Cancer rapid test kit of soluble fragment of cytokeratin-19 (CYFRA21-1) ) testing in ELISA test,Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Tumor/Cancer test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody.The antigens can be used for antibodies rapid test of Tumor/Cancer.

Order information

Description